1. Home
  2. VYX vs VOR Comparison

VYX vs VOR Comparison

Compare VYX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NCR Voyix Corporation

VYX

NCR Voyix Corporation

HOLD

Current Price

$8.20

Market Cap

1.1B

Sector

N/A

ML Signal

HOLD

Logo Vor Biopharma Inc.

VOR

Vor Biopharma Inc.

N/A

Current Price

$23.46

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VYX
VOR
Founded
1881
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.4B
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
VYX
VOR
Price
$8.20
$23.46
Analyst Decision
Strong Buy
Buy
Analyst Count
6
10
Target Price
$13.67
$45.33
AVG Volume (30 Days)
2.1M
786.7K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,156,000,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
15.29
N/A
52 Week Low
$6.02
$1.90
52 Week High
$13.77
$49.95

Technical Indicators

Market Signals
Indicator
VYX
VOR
Relative Strength Index (RSI) 50.49 60.10
Support Level $7.52 $21.75
Resistance Level $8.46 $24.44
Average True Range (ATR) 0.36 1.12
MACD -0.03 -0.14
Stochastic Oscillator 55.71 64.87

Price Performance

Historical Comparison
VYX
VOR

About VYX NCR Voyix Corporation

NCR Voyix Corp is a company providing services of digital commerce solutions for retail, restaurant, and digital banking. The company operates in two reportable segments: Retail, and Restaurants. The Retail segment provides software solutions for retailers of all sizes, enhancing operational efficiency and customer experience. The Restaurants segment offers end-to-end technology solutions for food service establishments, improving operational efficiency, and customer satisfaction, and reducing costs. The company derives maximum revenue from Retail segment. Geographically, the company operates in United States, Americas (excluding United States), Europe, Middle East and Africa, and Asia Pacific. It derives maximum revenue from United States.

About VOR Vor Biopharma Inc.

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Share on Social Networks: